Shenzhen HighTide Biopharmaceutical Co.,Ltd
君圣泰
Shenzhen HighTide Biopharmaceutical Co.,Ltd
Biotech/Healthcare
HighTide Therapeutics is a clinical-stage biopharmaceutical company developing novel drugs to address major unmet clinical needs in chronic liver diseases, gastrointestinal disorders, and metabolic diseases. The company is advancing first-in-class therapies globally and in parallel.
Latest round: IPO (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.